BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 32483653)

  • 1. Sequential
    Bomanji J; Sharma R; Mittal BR; Gambhir S; Qureshy A; Begum SMF; Paez D; Sathekge M; Vorster M; Sobic Saranovic D; Pusuwan P; Mann V; Vinjamuri S; Zumla A; Pascual TNB
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3118-3129. PubMed ID: 32483653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT features of extrapulmonary tuberculosis at first clinical presentation: a cross-sectional observational
    Bomanji J; Sharma R; Mittal BR; Gambhir S; Qureshy A; Begum SMF; Paez D; Sathekge M; Vorster M; Sobic Saranovic D; Pusuwan P; Mann V; Vinjamuri S; Zumla A; Pascual TNB;
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31831584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients?
    Sood A; Mittal BR; Modi M; Chhabra R; Verma R; Rana N; Parihar AS; Satapathy S; Kumar R
    Clin Nucl Med; 2020 Apr; 45(4):276-282. PubMed ID: 32108701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards more accurate
    Priftakis D; Riaz S; Zumla A; Bomanji J
    Int J Infect Dis; 2020 Mar; 92S():S85-S90. PubMed ID: 32114199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients: An Exploratory Study.
    Martin C; Castaigne C; Vierasu I; Garcia C; Wyndham-Thomas C; de Wit S
    Clin Nucl Med; 2018 Sep; 43(9):635-640. PubMed ID: 30015658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-CT-guided characterisation of progressive, preclinical tuberculosis infection and its association with low-level circulating Mycobacterium tuberculosis DNA in household contacts in Leicester, UK: a prospective cohort study.
    Kim JW; Bowman K; Nazareth J; Lee J; Woltmann G; Verma R; Sharifpour M; Shield C; Rees C; Kamil A; Swift B; Haldar P
    Lancet Microbe; 2024 Feb; 5(2):e119-e130. PubMed ID: 38244554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.
    Razak HR; Geso M; Abdul Rahim N; Nordin AJ
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):556-62. PubMed ID: 22141602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis.
    Tian G; Xiao Y; Chen B; Xia J; Guan H; Deng Q
    Acta Radiol; 2010 Nov; 51(9):1002-6. PubMed ID: 20942732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis.
    Jeong YJ; Paeng JC; Nam HY; Lee JS; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    J Korean Med Sci; 2014 Mar; 29(3):386-91. PubMed ID: 24616588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis.
    Stelzmueller I; Huber H; Wunn R; Hodolic M; Mandl M; Lamprecht B; Schinko H; Fellner F; Skanjeti A; Giammarile F; Colletti PM; Rubello D; Gabriel M
    Clin Nucl Med; 2016 Apr; 41(4):e187-94. PubMed ID: 26704732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
    Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploration of the feasibility and clinical value of half-dose 5-h total-body
    Adili D; Cai D; Wu B; Yu H; Gu Y; Zhang Y; Shi H
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2375-2385. PubMed ID: 36864361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.
    Vorster M; Sathekge MM; Bomanji J
    Curr Opin Pulm Med; 2014 May; 20(3):287-93. PubMed ID: 24614238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of
    Lefebvre N; Argemi X; Meyer N; Mootien J; Douiri N; Sferrazza-Mandala S; Schramm F; Weingertner N; Christmann D; Hansmann Y; Imperiale A
    Nucl Med Biol; 2017 Jul; 50():17-24. PubMed ID: 28426991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study.
    Geadas C; Acuna-Villaorduna C; Mercier G; Kleinman MB; Horsburgh CR; Ellner JJ; Jacobson KR
    BMC Res Notes; 2018 Jul; 11(1):464. PubMed ID: 30001743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.